New study shows Prolacta’s human milk-based nutritional fortifiers save hospital NICUs up to $3.4M annually
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Length of hospital stay Necrotizing Entercolitis (NEC)
Study reveals Prolacta’s 100% human milk-based nutritional fortifiers significantly increase bioactive proteins and antioxidant activity in human milk samples, outperforming cow milk-based fortifier
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Probiotics Product
Prolacta Bioscience celebrates donor moms on World Human Milk Donation Day
Type: Press Releases
Topic(s): Company Donors
Prolacta Bioscience recognizes contributions of breast milk donors during National Nutrition Month
Type: Press Releases
Topic(s): Company Parents
The Prolacta Bioscience Foundation empowers parents and communities with over half a million dollars in grant funding in 2022
Type: Press Releases
Topic(s): Company Parents
Hot Topics in Neonatology 2022 Conference will include symposium on benefits of vat pasteurization for human donor milk
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Company Conferences and Events Microbiome Probiotics
Prolacta Clinical Advisory Board members present webinar on improved growth metrics for preterm infants fed an exclusive human milk diet
Type: Press Releases
Topic(s): Feeding Protocols Growth
Prolacta Bioscience celebrates Prematurity Awareness Month and World Prematurity Day by recognizing the contributions of breast milk donors, parents of premature infants, and the NICU teams who care for them
Type: Press Releases
Topic(s): 22-27 weeks (extremely premature) Company Donors Growth Long-Term outcomes
New study finds improved long-term neurodevelopmental outcomes for extremely premature infants fed Prolacta’s exclusive human milk diet (EHMD)
Type: Press Releases
Topic(s): Long-Term outcomes Neurodevelopmental Outcomes
